Padagis extends shelf life for OTC naloxone HCl Nasal spray
Padagis, a generic manufacturer, shared that its over-the-counter Naloxone HCl Nasal Spray 4 mg has now obtained an extended shelf-life of 36 months.
Padagis’ Naloxone HCl Nasal Spray is an original prescription-strength medication designed to rapidly reverse the effects of a life-threatening opioid overdose.
The shelf-life extension is another example of Padagis’ commitment to reducing healthcare costs and improving accessibility by delivering high-quality medicines through innovative approaches, the company said.
[Read more: Padagis debuts generic Tobradex]
“We believe every patient should have affordable access to the medication that best serves their needs especially when it comes to the opioid crisis,” said Pamela Hoffman, president of Padagis."Our commitment to expanding access is stronger than ever, which we believe strongly contributes to the recent trends indicating that opioid overdose deaths are declining. At just $29.99 for a two-dose pack, Padagis 4 mg naloxone nasal spray remains the most affordable OTC option available to consumers on Amazon, and now, with a longer shelf life, we're delivering even greater value to those who need it most."
The three-year expiration will apply to newly manufactured medicine that is planned to be released by Padagis as early as late second quarter of this year. Padagis encourages all customers and consumers to follow the expiration date printed on the product packaging.
[Read more: Padagis will not seek FDA approval for generic Phexxi until Evofem's patents expire]